Michael L Dansinger
Overview
Explore the profile of Michael L Dansinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
742
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dansinger M, Breton G, Joly J, Rhee L, Katz D
Am J Health Promot
. 2023 Feb;
37(6):835-840.
PMID: 36772929
Purpose: To examine the associations between dietary intake as assessed by a rapid, image-based digital tool and biomarkers of cardiometabolic health. Design: Retrospective analysis of adults with blood biomarkers performed...
2.
Diffenderfer M, Rajapakse N, Pham E, He L, Dansinger M, Nelson J, et al.
J Clin Lipidol
. 2022 Feb;
16(2):184-197.
PMID: 35120898
Background: Fatty acids (FA) play an important role in health and heart disease risk. Objective: We evaluated relationships of plasma FA levels, especially omega-3 FA, with sex, age, and reported...
3.
Katz D, Dansinger M, Willett W, Rifai T, Rhee L, Gardner C, et al.
Am J Health Promot
. 2021 Jun;
35(6):874-882.
PMID: 34120475
No abstract available.
4.
Katz D, Dansinger M, Willett W
Am J Health Promot
. 2021 Jun;
35(6):875-878.
PMID: 34120471
No abstract available.
5.
Schaefer E, Dulipsingh L, Comite F, Jimison J, Grajower M, Lebowitz N, et al.
PLoS One
. 2021 Jun;
16(6):e0252818.
PMID: 34111164
Most deaths from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection occur in older subjects. We assessed the utility of serum inflammatory markers interleukin-6 (IL-6), C reactive protein (CRP), and ferritin...
6.
Dansinger M, Williams P, Superko H, Schaefer E
Lipids Health Dis
. 2019 Jul;
18(1):154.
PMID: 31311555
Background And Aims: Non-high-density (HDL)-cholesterol, low-density lipoprotein (LDL)-particle number, apolipoprotein B, lipoprotein(a) (Lp(a)), and small-dense (sdLDL) and large-buoyant (lbLDL) LDL-subfractions are emerging apo B-containing atherosclerotic cardiovascular disease (ASCVD) risk factors....
7.
Dansinger M, Williams P, Superko H, Schaefer E
Prev Med
. 2019 Feb;
121:150-157.
PMID: 30742874
Under "treat to risk" goals, low-density (LDL)-cholesterol follow-up measurements monitor statin compliance rather than titration to target levels, however, there is little evidence showing that more-frequent monitoring reduces LDL-cholesterol. We...
8.
Asztalos I, Gleason J, Sever S, Gedik R, Asztalos B, Horvath K, et al.
Metabolism
. 2016 Oct;
65(11):1636-1645.
PMID: 27733252
Background: Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), the primary omega-3 fatty acids in fish oil, have been shown to reduce cardiovascular disease (CVD) risk. Objective: This study aimed to...
9.
Schaefer E, Gleason J, Dansinger M
J Nutr
. 2009 May;
139(6):1257S-1262S.
PMID: 19403705
Absorbed glucose and fructose differ in that glucose largely escapes first-pass removal by the liver, whereas fructose does not, resulting in different metabolic effects of these 2 monosaccharides. In short-term...
10.
Godfrey J, Dansinger M
J Womens Health (Larchmt)
. 2009 Apr;
18(4):435-8.
PMID: 19361308
No abstract available.